TickerFacts.

AbbVie Inc. (ABBV): Net Income

Annual figures by period end, from SEC filings.

$4.23B
Year ended 2025-12-31
$6.31B
Trailing 12 months to 2026-06-30
-29.1%
3-year compound annual growth
-1.7%
5-year compound annual growth
-1.9%
10-year compound annual growth
$11.84B2014-12-31: $1.77B2015-12-31: $5.14B2016-12-31: $5.95B2017-12-31: $5.31B2018-12-31: $5.69B2019-12-31: $7.88B2020-12-31: $4.62B2021-12-31: $11.54B2022-12-31: $11.84B2023-12-31: $4.86B2024-12-31: $4.28B2025-12-31: $4.23B$4.23B
2014-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31$4.23B-1.2%2026-02-20, From 2025-01-01
2024-12-31$4.28B-12.0%2026-02-20, From 2024-01-01
2023-12-31$4.86B-58.9%2026-02-20, From 2023-01-01
2022-12-31$11.84B+2.5%2025-02-14, From 2022-01-01
2021-12-31$11.54B+150.0%2024-02-20, From 2021-01-01
2020-12-31$4.62B-41.4%2023-02-17, From 2020-01-01
2019-12-31$7.88B+38.6%2022-02-18, From 2019-01-01
2018-12-31$5.69B+7.1%2021-02-19, From 2018-01-01
2017-12-31$5.31B-10.8%2020-02-21, From 2017-01-01
2016-12-31$5.95B+15.7%2019-02-27, From 2016-01-01
2015-12-31$5.14B+190.0%2018-02-16, From 2015-01-01
2014-12-31$1.77Bn/a2017-02-17, From 2014-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
AbbVie Inc. (ABBV)2025-12-31$4.23B-1.2%
Pfizer Inc (PFE)2025-12-31$7.77B-3.2%
Merck & Co., Inc. (MRK)2025-12-31$18.25B+6.6%
Eli Lilly & Co (LLY)2025-12-31$20.64B+94.9%
Bristol Myers Squibb Co (BMY)2025-12-31$7.05Bn/m
Abbott Laboratories (ABT)2025-12-31$6.52B-51.3%
Johnson & Johnson (JNJ)2025-12-28$26.80B+90.6%
Teva Pharmaceutical Industries Ltd (TEVA)2025-12-31$1.41Bn/m
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$4.50B+2.1%

Compare ABBV, PFE, MRK, LLY side by side · Screen every company in Pharmaceutical Preparations ↗